IGKC and neoplasm: To validate our immunohistochemical results on the prognostic impact of the plasma cell markers IgκC and CD38 in a larger, independent cohort of TNBC, we used the publicly available gene expression data of IgκC and CD38 with their associated tumor characteristics and follow-up data [27] in a cohort of 424 TNBC samples.